Research findings, pricing news, and vendor analysis across the peptide market.
Posts about Retatrutide
Showing 1 to 2 of 2
The compounded GLP-1 market has not fully shut down, but it has shifted. This tracker shows which telehealth providers now emphasize brand or direct-pay routes, which still advertise compounded semaglutide or tirzepatide, and what FDA says buyers should verify before paying.
Read more →The Trump administration announced deals with Eli Lilly and Novo Nordisk to significantly reduce the cost of weight loss medications through TrumpRx. Here's what we know and what it means for people taking semaglutide or tirzepatide.
Read more →STOP PIECING IT TOGETHER
We wrote the shortcut: five books, 45 compounds, every claim graded by the strength of the real evidence. No hype, no gatekeeping, and free updates for life whenever the market shifts. Most readers say it replaces months of forum digging.
